Elucidation of the Molecular Mechanism Underlying Function of Therapeutic Antibodies and the Development of Quality Assessment Methods
Open Access
- 1 September 2026
- journal article
- Published by Pharmaceutical Society of Japan in YAKUGAKU ZASSHI
- Vol. 146 (9) , 757-763
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Fifty years of monoclonals: the past, present and future of antibody therapeuticsNature Reviews Immunology, 2025
- The Structural Fingerprint of Therapeutic Monoclonal Antibodies Determined Using a Combination of Near-UV Circular Dichroism and Statistical Approach for Comparative AnalysisAnalytical Chemistry, 2025
- Specific peptide conjugation to a therapeutic antibody leads to enhanced therapeutic potency and thermal stability by reduced Fc dynamicsScientific Reports, 2023
- A Comparison Between Emerging and Current Biophysical Methods for the Assessment of Higher-Order Structure of BiopharmaceuticalsJournal of Pharmaceutical Sciences, 2020
- Site-Specific Chemical Conjugation of Antibodies by Using Affinity Peptide for the Development of Therapeutic Antibody FormatBioconjugate Chemistry, 2019
- Assessing the Heterogeneity of the Fc-Glycan of a Therapeutic Antibody Using an engineered FcγReceptor IIIa-Immobilized ColumnScientific Reports, 2018
- Glycosylation of IgG-Fc: a molecular perspectiveInternational Immunology, 2017
- Structural analysis of Fc/FcγR complexes: a blueprint for antibody designImmunological Reviews, 2015